Bio-Techne rebrands genome engineering as part of R&D Systems portfolio
September 21, 2020 -- Bio-Techne has rebranded its cell and gene engineering product offer as part of its R&D Systems biotechnology brand.
Moderna, Vertex collaborate on gene editing therapies for cystic fibrosis
September 17, 2020 -- Moderna and Vertex Pharmaceuticals have entered a three-year research collaboration for the discovery and development of lipid nanoparticles and messenger RNAs for the delivery of gene editing therapies for the treatment of cystic fibrosis.
Clinical test allows patients to be directly matched to clinical trial
September 16, 2020 -- Ashion Analytics has partnered with Elevation Oncology to match patients harboring an NRG1 gene fusion identified with Ashion's Gem Extra test with a phase II clinical study of seribantumab, an investigational monoclonal antibody treatment for advanced solid tumors.
ERS Genomics inks licensing agreement with Applied StemCell
September 15, 2020 -- ERS Genomics said that it has signed a licensing agreement with Applied StemCell to commercialize CRISPR gene editing services and reagents.
Hexagon Bio secures $47M to advance drug discovery platform
September 15, 2020 -- Hexagon Bio has closed $47 million in series A financing to advance its drug discovery capabilities on its fungal genomics-based platform.
Sherlock launches nonprofit to promote equity, STEM during COVID-19
September 15, 2020 -- Sherlock Biosciences has formed the 221b Foundation, a nonprofit organization committed to assisting in the eradication of COVID-19, while supporting racial and gender diversity in STEM.
J&J calls for applicants for women in STEM award
September 14, 2020 -- Johnson & Johnson is now accepting applications for its 2021 women in STEM disciplines award.
Thermo Fisher center forms partnerships for biomarkers
September 14, 2020 -- Thermo Fisher Scientific announced new collaborations for clinical biomarker discovery among the Thermo Fisher Precision Medicine Science Center, AstraZeneca, and the University of Nebraska Medical Center.
Neogene Therapeutics to develop personalized cell therapies
September 14, 2020 -- Neogene Therapeutics is pioneering a new class of fully personalized neoantigen T-cell therapies to treat cancer supported by $110 million in series A financing.
Neurocrine, Voyager tout gene therapy clinical results for Parkinson's disease
September 11, 2020 -- Neurocrine Biosciences and Voyager Therapeutics have released data from a phase Ib open-label, three-year efficacy and safety study of NBIb-1817, an investigational gene therapy to improve motor function in patients with Parkinson's disease.
Conferences
ESMO Virtual Congress 2020
September 14-29
Online
BioProcess International West
September 21-25
Online
BioProcess International
September 21-25
Online
ASGCT 2020 Policy Summit
September 23-25
Online
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter